J-A QUIDEL ORTHOR.pdf
PDF 302 KB Posted
- Attached to
- J&A BRIDGE SOLE SOURCE QUIDELORTHO
- Solicitation number
- HT9406KM1
- Issued by
-
Defense Health Agency
About this file
This document is a Justification and Approval (J&A) Modified for Federal Acquisition Regulation (FAR) 13.501, prepared by the Defense Health Agency (DHA) for the 633rd Medical Group at Langley-Eustis Air Force Base. The document seeks approval for a sole source, firm fixed-price bridge contract with Ortho Clinical Diagnostics for Analyzer Cost Per Reportable supplies under GSA schedule V797D60637. The total estimated contract value is $382,684.80, covering a base period from 12/2/2025 to 9/30/2026 and an option period from 10/1/2026 to 4/1/2027.
The sole source justification stems from a protest that led to contract termination, necessitating a bridge contract to prevent a lapse in laboratory processing capabilities. The contract is being awarded to the incumbent due to insufficient time to develop a new requirement package and re-solicit. The Contracting Office plans to conduct market research, finalize the technical data package by 5 January 2026, and ultimately synopsize a new contract to promote competition. The requirement supports the medical group's ability to diagnose and treat patients, with potential major disruption of care for military personnel and dependents if the contract is not approved.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
CUI
CUI
Source Selection Information - See FAR 2.101 and 3.104-4
2 NOV 2024
5. Rationale Justifying Use of Authority Cited: In accordance with FAR 13.500 the proposed requirement has an estimated value of $382,684.80 which is under the Threshold of $9 million for Commercial Items. As documented in the contract file and attached, the proposed contract is a Bridge action due to a Protest, Ortho Clinical Diagnostics is the incumbent providing the supplies required under GSA schedule contract V797D60637 contract number FA480020F0085.
V797D60637 has an expiration date of 14 July 2026. The proposed Sole Source will allow the Government to avoid a lapse in analyzer costs per reportable supplies while a new contract requirement is processed.
6. Efforts to Obtain Competition: The proposed Sole Source Bridge contract cannot support obtaining competition as the Government has a reasonable expectation that no other vendor can meet the requirement in the required time, only the incumbent Ortho Clinical Diagnostics.
7. Actions to Increase Competition/Remove or Overcome any Barriers to Competition: In order to increase competition and/or remove barriers to competition, the Contracting Office is working with the 633rd MDG to ensure the requirement technical data package and its supporting documents are in line with protest corrective action determination. The requirement technical data package is anticipated to be finalized by 5 January 2026. With the requirement technical data package, the Contracting Office will identify via market research potential capable sources to promote competition, the new contract will be synopsized in accordance with FAR 5.2.
8. Market Research: Market research was conducted, and it was determined that the required Analyzer and supplies are still available from Ortho Clinical Diagnostics under GSA schedule V797D60637 to support the Bridge contract action.
9. Other Facts:
a. Procurement History:
(1) Is this a new requirement? No, the requirement is not new.
(2) If 9.a.(1) is No, was the action just prior to this one competed? Yes, the requirement was previously competed and received two offers as documented in the Federal Procurement Data System(FPDS). Resulting in the award of contract FA480020F0085 to Ortho Clinical Diagnostics.
(3) If 9.a.(2) is Yes, what has changed where this action cannot be competed? Due to the protest which its corrective action determined that the contract be terminated, there is no sufficient time to produce a revised requirement package and re-solicit therefore the only option is for a Bridge contract via Sole Source to the incumbent.
b. Additional Information: If this Sole Source is not approved the 633 MDG will experience a lapse in their capability to process laboratory results. The analyzer supports their
File details come from the government source that posted it. Updated .